Recent clinical applications of external beam radiotherapy for hepatocellular carcinoma according to guidelines, major trials and meta-analyses

Chai Hong Rim, Hyung Joon Yim, Sunmin Park, Jinsil Seong

    Research output: Contribution to journalReview articlepeer-review

    11 Citations (Scopus)

    Abstract

    External beam radiotherapy (EBRT) for hepatocellular carcinoma (HCC) has not been widely used due to lack of high-level evidence, despite its potent local therapeutic effect. While clinical evidence has accumulated and meta-analyses of observational studies have provided integrated information to help in clinical decision-making, a recent randomized trial demonstrated the benefit of EBRT in cases of HCC with major vessel invasion. Based on these trends, the efficacy of EBRT has been better recognized, and EBRT has been more frequently recommended in several international treatment guidelines newly updated in 2018. This review examined the key issues of EBRT in the guidelines updated in 2018 as well as recently published noteworthy randomized trials and meta-analyses. Ongoing trials to identify the trends and direction of future research on EBRT for HCC were also reviewed.

    Original languageEnglish
    Pages (from-to)812-821
    Number of pages10
    JournalJournal of Medical Imaging and Radiation Oncology
    Volume63
    Issue number6
    DOIs
    Publication statusPublished - 2019 Dec 1

    Keywords

    • external beam radiotherapy
    • guidelines
    • hepatocellular carcinoma
    • liver neoplasm
    • radiation therapy

    ASJC Scopus subject areas

    • Oncology
    • Radiology Nuclear Medicine and imaging

    Fingerprint

    Dive into the research topics of 'Recent clinical applications of external beam radiotherapy for hepatocellular carcinoma according to guidelines, major trials and meta-analyses'. Together they form a unique fingerprint.

    Cite this